Search

Author/Creator Matsumura, Mirai

1. Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer. Issue 4 (2nd February 2023)

Authors:
Hamai, Kosuke; Miyaka, Shinya; Tada, Shinpei; Fujita, Suguru; Hirakawa, Tetsu; Matsumura, Mirai; Ueno, Sayaka; Tanimoto, Takuya; Ishikawa, Nobuhisa
Journal:
Cancer reports
Issue:
Volume 6:Issue 4(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report. Issue 6 (14th April 2020)

Authors:
Hamai, Kosuke; Tanahashi, Hiroki; Ueno, Sayaka; Konishi, Hanae; Matsumura, Mirai; Nomura, Akio; Nakamoto, Kanako; Isoyama, Shoko; Tanimoto, Takuya; Shoda, Hiroyasu; Ishikawa, Nobuhisa
Journal:
Thoracic cancer
Issue:
Volume 11:Issue 6(2020)
Page Start:
1716
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1. Issue 11 (30th April 2022)

Authors:
Masuda, Takeshi; Fujitaka, Kazunori; Suzuki, Tomoko; Hamai, Kosuke; Matsumoto, Naoko; Matsumura, Mirai; Isoyama, Shoko; Ueno, Sayaka; Mito, Mineyo; Yamaguchi, Kakuhiro; Sakamoto, Shinjiro; Kawano, Reo; Masuda, Ken; Nishino, Ryohei; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Hattori, Noboru
Journal:
Thoracic cancer
Issue:
Volume 13:Issue 11(2022)
Page Start:
1611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search